Here, we obtained clinical proteomic data from three independently published HCC cohorts and identified LUC7-like 3 pre-mRNA splicing factor as a prognostic biomarker for patients with HCC. This evidence concerns the gene LUC7L3 and hepatocellular carcinoma.